Opportunity Information: Apply for RFA DK 15 009
Apply for RFA DK 15 009
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Translational Research to Improve Outcomes in Kidney Diseases (R18)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on May 5, 2015 and posted on May 5, 2015.
- Applicants must submit their applications by Nov 18, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $225,000.00 in funding.
- Eligible applicants include: County governments State governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Independent school districts Private institutions of higher education Special district governments For profit organizations other than small businesses City or township governments Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Translational Research to Improve Outcomes in Kidney Diseases (R18)" (Funding Opportunity Number RFA-DK-15-009) is a National Institutes of Health (NIH) Funding Opportunity Announcement designed to move proven kidney disease prevention and treatment strategies closer to real-world use. Instead of funding early-stage discovery work, this R18 mechanism focuses on demonstration and dissemination research: projects that take interventions or approaches already shown to work (efficacious strategies) and adapt them so they are practical in everyday clinical and community settings. The emphasis is on making these approaches sustainable over time, acceptable to patients and providers, and cost-efficient, with a clear pathway for broader implementation if the project succeeds.
The research scope is specifically tied to kidney disease outcomes. Proposed projects must target either preventing kidney disease, improving the care of people who already have kidney disease, or preventing or delaying kidney-related complications. In practical terms, that could include testing implementation-ready models of care, improving care coordination, adapting patient education or self-management supports, strengthening screening or early detection workflows, integrating evidence-based protocols into health systems, or tailoring proven interventions for high-risk groups and real service environments. A key expectation is that the approach being tested should be capable of being widely disseminated, meaning it should have realistic potential to spread beyond a single research site into routine clinical practice and/or into communities and populations at risk.
This opportunity is categorized as discretionary grant funding, using the NIH R18 research demonstration and dissemination project grant mechanism. It falls under the NIH activity category connected to health (CFDA 93.847, Diabetes, Digestive, and Kidney Diseases Extramural Research), reflecting that it is part of the NIH portfolio supporting applied research in kidney-related conditions. The total estimated funding amount listed for the FOA is $1,500,000, and the award ceiling is $225,000 (meaning individual awards are expected not to exceed that amount under the terms posted). There is no cost sharing or matching requirement, which reduces the burden on applicants to bring external matching funds.
A broad range of applicants are eligible, which signals that NIH intended this FOA to support work across health systems, public agencies, education-based institutions, and community settings. Eligible applicants include state and local governments (including county and city/township governments), public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (including 501(c)(3) organizations and certain nonprofits without 501(c)(3) status), for-profit organizations (including small businesses and other for-profits), independent school districts, special district governments, public housing authorities/Indian housing authorities, and tribal governments and tribal organizations (including federally recognized tribal governments and other tribal entities). The eligibility list also explicitly highlights a variety of mission-focused and historically underserved-serving institutions and organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based and community-based organizations, regional organizations, and U.S. territories or possessions. At the same time, non-U.S. (foreign) institutions are not eligible, and foreign components are not allowed, including non-domestic components of U.S. organizations as defined by NIH policy.
Timing details in the source indicate the FOA was posted and created on May 5, 2015, with an original and current closing date of November 18, 2015, and an archive date of December 19, 2015. While those dates indicate this specific announcement is no longer active, the structure and intent are still useful as a reference for the type of translational, implementation-focused kidney disease research NIH has sought to fund through the R18 mechanism. The full announcement was made available through the NIH grants guide at the link provided in the source material.
Overall, the central idea of this funding opportunity is to close the gap between what has been shown to work in controlled research environments and what can realistically be delivered at scale in everyday healthcare and community contexts. Successful applications under this FOA would be expected to show a clear evidence base for the strategy being adapted, a thoughtful plan for real-world implementation, attention to feasibility and cost, and outcomes that matter for kidney disease prevention, care quality, and complication reduction, with strong potential for dissemination beyond the initial project setting.
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled "Translational Research to Improve Outcomes in Kidney Diseases (R18)."
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is RFA-DK-15-009.
Which federal agency is offering this opportunity?
This is a National Institutes of Health (NIH) Funding Opportunity Announcement.
What is the overall purpose of this FOA?
The purpose is to move proven kidney disease prevention and treatment strategies closer to real-world use by supporting demonstration and dissemination research. The focus is on adapting interventions that already work so they are practical, sustainable, acceptable, and cost-efficient in everyday clinical and community settings, with a clear pathway for broader implementation if successful.
What does "translational research" mean in this FOA?
In this FOA, translational research refers to closing the gap between strategies that have been shown to work in controlled research settings and approaches that can be delivered at scale in routine healthcare and community environments.
What NIH grant mechanism is used for this program?
This opportunity uses the NIH R18 research demonstration and dissemination project grant mechanism.
Is this FOA intended for early-stage discovery research?
No. The R18 mechanism described here is not focused on early-stage discovery work. It is focused on demonstration and dissemination research using interventions or approaches that have already been shown to be efficacious.
What kinds of projects are in scope?
Projects must target kidney disease outcomes and focus on either preventing kidney disease, improving care for people who already have kidney disease, or preventing or delaying kidney-related complications. The emphasis is on implementation-ready strategies that can work in real service environments.
What are examples of activities that could fit within the scope described?
Examples mentioned include testing implementation-ready models of care, improving care coordination, adapting patient education or self-management supports, strengthening screening or early detection workflows, integrating evidence-based protocols into health systems, or tailoring proven interventions for high-risk groups in real-world clinical and community settings.
What does NIH mean here by "demonstration and dissemination" research?
It refers to projects that demonstrate how proven strategies can be implemented in everyday settings and generate evidence that supports broader dissemination, rather than testing whether an intervention works for the first time.
What level of prior evidence is expected for the intervention or strategy being proposed?
The FOA emphasizes strategies that have already been shown to work (efficacious strategies). Applications would be expected to show a clear evidence base for the approach being adapted.
What outcomes does the FOA care about?
Outcomes should matter for kidney disease prevention, quality of care for individuals with kidney disease, and prevention or delay of kidney-related complications. The FOA also emphasizes feasibility, cost-efficiency, acceptability to patients and providers, sustainability over time, and the ability to disseminate broadly if successful.
What does "sustainable over time" imply for proposed projects?
It implies the project should be designed so that the approach can continue in routine practice beyond the study period, rather than relying on short-term, research-only supports.
What does "acceptable to patients and providers" mean in this context?
It means the adapted strategy should be realistic and workable in everyday care, aligning with patient needs and provider workflows so it can be used consistently in real settings.
What does "cost-efficient" mean in this FOA?
The FOA highlights cost-efficiency as a priority, indicating projects should consider practicality and resource needs so the approach can be maintained and scaled in clinical and/or community settings.
Is there an expectation that the project can expand beyond a single site?
Yes. A key expectation is that the approach should be capable of being widely disseminated, meaning it should have realistic potential to spread beyond a single research site into routine clinical practice and/or into communities and populations at risk.
What is the total estimated funding amount for this FOA?
The total estimated funding amount listed is $1,500,000.
What is the award ceiling?
The award ceiling is $225,000, meaning individual awards are expected not to exceed that amount under the terms posted.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement.
How is this funding categorized?
It is categorized as discretionary grant funding using an NIH activity category connected to health.
What CFDA program is associated with this opportunity?
The CFDA number listed is 93.847, Diabetes, Digestive, and Kidney Diseases Extramural Research.
Who is eligible to apply?
A broad range of applicants are eligible, including state and local governments (including county and city/township governments), public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (including 501(c)(3) organizations and certain nonprofits without 501(c)(3) status), for-profit organizations (including small businesses and other for-profits), independent school districts, special district governments, public housing authorities/Indian housing authorities, and tribal governments and tribal organizations.
Are community-based and faith-based organizations eligible?
Yes. The eligibility list explicitly includes faith-based and community-based organizations.
Are minority-serving institutions specifically included?
Yes. The eligibility list explicitly highlights Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
Are U.S. territories or possessions eligible?
Yes. The eligibility list includes U.S. territories or possessions.
Are tribal entities eligible?
Yes. Eligible applicants include tribal governments and tribal organizations, including federally recognized tribal governments and other tribal entities.
Are non-U.S. (foreign) institutions eligible to apply?
No. Non-U.S. (foreign) institutions are not eligible.
Are foreign components allowed as part of a U.S. organization?
No. Foreign components are not allowed, including non-domestic components of U.S. organizations as defined by NIH policy.
When was this FOA posted?
The FOA was posted (and created) on May 5, 2015.
What was the closing date for applications?
The original and current closing date listed is November 18, 2015.
Is this announcement still active?
No. The archive date is December 19, 2015, and the listed closing date has passed, indicating this specific announcement is no longer active.
Where was the full announcement made available?
The full announcement was made available through the NIH grants guide at the link provided in the source material.
What would a strong application be expected to demonstrate, based on the description provided?
Based on the description, strong applications would be expected to show a clear evidence base for the strategy being adapted, a thoughtful plan for real-world implementation, attention to feasibility and cost, outcomes that matter for kidney disease prevention/care/complication reduction, and strong potential for dissemination beyond the initial project setting.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: Development and Application of Case Control Analysis for Generic Drugs (U01)
Previous opportunity: BJA FY 15 PREA Program National PREA Resource Center
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DK 15 009
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DK 15 009) also looked into and applied for these:
| Funding Opportunity |
|---|
| Integrated Food Defense Apply for RFA FD 15 022 Funding Number: RFA FD 15 022 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $100,000 |
| Integrated Food Safety System Online Collaboration Development (U18) Apply for RFA FD 15 024 Funding Number: RFA FD 15 024 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $680,000 |
| FDA Drug Residue Cooperative Agreement Program (U18) Apply for RFA FD 15 025 Funding Number: RFA FD 15 025 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $125,000 |
| Limited Competition Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) (U18) Apply for RFA FD 15 018 Funding Number: RFA FD 15 018 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $70,000 |
| Implementation of the Animal Feed Regulatory Program Standards (AFRPS) (U18) Apply for RFA FD 15 021 Funding Number: RFA FD 15 021 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $750,000 |
| Food Protection Rapid Response Team (RRT) (U18) Apply for RFA FD 15 020 Funding Number: RFA FD 15 020 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $450,000 |
| Adherence Studies in Adolescents with Chronic Kidney or Urologic Diseases (R01) Apply for RFA DK 15 017 Funding Number: RFA DK 15 017 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $450,000 |
| NIDDK Centers for Diabetes Translation Research (P30) Apply for RFA DK 15 003 Funding Number: RFA DK 15 003 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Expanding Course Offerings for State and Local Regulators in the Integrated Food Safety System (U18) Apply for RFA FD 15 039 Funding Number: RFA FD 15 039 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $1,000,000 |
| A Community Research Resource of Microbiome Derived Factors Modulating Host Physiology in Obesity, Digestive and Liver Diseases, and Nutrition (R24) Apply for RFA DK 15 012 Funding Number: RFA DK 15 012 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Exploratory Studies for Delineating Microbiome Host Interactions in Obesity, Digestive and Liver Diseases and Nutrition (R21) Apply for RFA DK 15 013 Funding Number: RFA DK 15 013 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
| Exploration of the Roles of Brown and Beige Adipose Tissue in Humans (R01) Apply for RFA DK 15 031 Funding Number: RFA DK 15 031 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Expanding FDAs Produce Safety and Instructor Skills Training under the Food Safety Modernization Act Apply for RFA FD 15 041 Funding Number: RFA FD 15 041 Agency: Food Drug Administration Category: Food and Nutrition Health Funding Amount: $2,000,000 |
| Mechanisms Underlying the Contribution of Type 1 Diabetes Risk Associated Variants (DP3) Apply for RFA DK 15 025 Funding Number: RFA DK 15 025 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $600,000 |
| Mouse Metabolic Phenotyping Centers Consortium (U2C) Apply for RFA DK 15 010 Funding Number: RFA DK 15 010 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Coordinating and Bioinformatics Unit for the Mouse Metabolic Phenotyping Centers and the Diabetic Complications Consortium (U24) Apply for RFA DK 15 011 Funding Number: RFA DK 15 011 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $10,100,000 |
| Limited Competition for the Continuation of Teen LABS (Adolescent Longitudinal Assessment of Bariatric Surgery) Clinical Centers (Collaborative U01) Apply for RFA DK 15 508 Funding Number: RFA DK 15 508 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Limited Competition for the Continuation of Teen LABS (Adolescent Longitudinal Assessment of Bariatric Surgery) Biostatistics Research Center (Collaborative U01) Apply for RFA DK 15 509 Funding Number: RFA DK 15 509 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| GenitoUrinary Development Molecular Anatomy Project (GUDMAP) Atlas Projects (U01) Apply for RFA DK 15 014 Funding Number: RFA DK 15 014 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| GenitoUrinary Development Molecular Anatomy Project (GUDMAP) Database/Website Project (U24) Apply for RFA DK 15 015 Funding Number: RFA DK 15 015 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 15 009", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.